In 15 patients with RA, as well as in 8 disease controls (osteoarthritis n = 4, PsA n = 4) the phenotype of B cells (either GM-CSF+ or −) was assessed by flow cytometry (Figure 2). This evidence concerns the gene CSF2 and rheumatoid arthritis.